Vincent graduated with a MSc degree in Medical Biology from the University of Amsterdam, where he also obtained a PhD in Biochemistry. His doctoral research focused on the phospholipid flippase ATP8B1 and its role in intracellular trafficking. This work resulted in three first-authored experimental publications in highly-ranked scientific journals.
Following this Vincent continued to work in academia as a post-doctoral researcher in the Academic Medical Center in Amsterdam. Using direct input from the pharmaceutical industry he developed and studied several cell culture systems that can act as models for drug metabolism and toxicity testing. He also became the main inventor on a patent application for a new improved liver cell line with potential use in a bio-artificial liver system.
Vincent went on to work as an analyst in the Healthcare team of M Ventures, the corporate venture capital arm of Merck KGaA, where he performed due diligence on technical, commercial and patented features of new investment proposals in the fields of (immuno-)oncology and immunology.
Prior to joining HGF, Vincent worked in the technology transfer office of the University of Leiden, specifically at the Leiden University Medical Center. Here, his roles included scouting for new (patentable) inventions, IP management, business development, advising on start-ups and investments, licencing and research agreements. During this time he came into contact with many cutting-edge technologies in the field of medical devices, diagnostic methods, software applications, antibodies, and cancer neoepitopes.
At HGF Vincent gained ample experience with patenting agrochemicals and various other subjects that combine chemistry and biology.
HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …Event details
HGF is a premium sponsor of the pro-manchester Health Tech conference on Friday 9th December. This conference looks at exploring what new and innovative ideas have been developed in the …Event details
From 1 November 2022, the EPO has announced changes to the procedure for remedying patent applications that contain parts that have been included erroneously and updated the procedure for filing …Read article
HGF is hosting a webinar on 10th November to discuss ‘Basics and news about Unified Patent Court’. Date 10th November, 2022 Time 14:00 – approx. 15:30 (CET) About the webinar …Event details
HGF is a gold sponsor of the Technology Patent Network Conference on Thursday 3rd November 2022 in San Jose. This conference looks at bringing together the industry’s most innovative companies …Event details
IIPLA 2022 USA is a two-day conference event taking place in Las Vegas on 10-11 October. Experts on Intellectual Property will share the stage to share fresh perspectives, data-driven approaches, …Event details
HGF hosted a webinar on 25th October to discuss ‘Litigating in the Unified Patent Court’. Date 25th October, 2022 Time Session 1 – 7:00 (BST) / 8:00 (CEST) / 15:00 …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.